Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Schering AG Stories

2013-05-21 08:30:22

NORTH BRUNSWICK, N.J., May 21, 2013 /PRNewswire/ -- Hurel Corporation ("Hurel"), a world-leading provider of advanced artificial tissue constructs and microfluidic cell-based assay platforms, today announced the appointment of James S. MacDonald, PhD, DABT to the Company's Board of Directors. Dr. MacDonald is the former Executive Vice President of Preclinical Development of the Schering-Plough Research Institute ("SPRI"), which was the pharmaceutical development arm of Schering Corporation...

2012-11-15 08:29:59

Merck's hepatitis C treatment receives prestigious Innovative Product Award KIRKLAND, QC, Nov. 15, 2012 /CNW/ - Merck is proud to announce that VICTRELIS(TM) (boceprevir), a first-in-class oral hepatitis C virus (HCV) protease inhibitor for the treatment of chronic hepatitis C (CHC) genotype 1 infection, received the Prix Galien Canada 2012 - Innovative Product Award. The most prestigious award in the field of Canadian pharmaceutical research and innovation,(1) this annual honour is...

2012-09-18 02:28:03

BETHESDA, Md., Sept. 18, 2012 /PRNewswire/ -- Northwest Biotherapeutics (OTC.BB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that it has appointed former pharmaceutical industry executive Dr. Gunter Rosskamp as the CEO of the Company's German subsidiary, Northwest Biotherapeutics, Gmbh. (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO) Dr. Rosskamp brings extensive experience as a senior manager in...

2012-05-10 06:24:08

WHITEHOUSE STATION, N.J., May 10, 2012 /PRNewswire/ -- A new nationwide survey commissioned by Merck, the maker of DR. SCHOLL'S products, found that 9 of out 10 Americans (91%) have experienced some type of foot pain, among those more than half (56%) have missed an event or an activity due to foot problems, and four of 10 Americans believe that foot aches and pains get in the way of walking more. The survey also found that New York City tops the list of cities where Americans 'walk the...

2012-03-14 10:21:00

CAMBRIDGE, England, March 14, 2012 /PRNewswire/ -- Mundipharma International has appointed Paul Medeiros to head its corporate and business development operations. In this position, Mr. Medeiros will join the Executive Leadership Team and play a critical role in extending and expanding avenues for corporate growth within Mundipharma's European independent associated companies, many of which are growing faster than any other midsized pharmaceutical companies in the market. Mr. Medeiros...

2012-01-04 07:00:00

MORRISTOWN, N.J., Jan. 4, 2012 /PRNewswire/ -- Five years after being acquired by Bayer, Intendis, Inc., makers of dermatology brands Finacea® (azelaic acid) Gel, 15% and Desonate® (desonide) Gel 0.05%, will change its name to Bayer HealthCare. Under this new name, the unit will continue to build on Intendis' long-standing dedication to dermatologists, patients and passion for skin health. "Although Intendis, Inc. will have a new name and a new look, the company's pioneering...

2011-11-28 06:00:00

MIAMI, Nov. 28, 2011 /PRNewswire/ -- Femina Pharma Incorporated announces the issuance of Order 24 in Investigation No. 337-TA-768 (In the matter of Certain Vaginal Ring Birth Control Devices) by the Administrative Law Judge at the United States International Trade Commission ("ITC") denying the Merck Respondents' Motion for Summary Determination on the basis of lack of Domestic Industry. The issuance of Order 24 follows the prior issuance on July 15, 2011 of Order 14 denying Merck's Motion...

2011-08-02 07:00:00

MIAMI, Aug. 2, 2011 /PRNewswire/ -- Femina Pharma Incorporated announced that Order No. 16 in Investigation No. 337-TA-768 (In the matter of Certain Vaginal Ring Birth Control Devices) was issued by the Chief Administrative Law Judge ("CALJ") at the United States International Trade Commission ("ITC") finding fourteen parties - thirteen Canadian Internet pharmacies and one U.S. Internet pharmacy -- in default. On February 11, 2011, Femina Pharma Incorporated filed a complaint with the...

2011-07-20 07:00:00

MIAMI, July 20, 2011/PRNewswire-USNewswire/ -- Femina Pharma Incorporated announced that Order No. 14 in Investigation No. 337-TA-768 (In the matter of Certain Vaginal Ring Birth Control Devices) was issued by the Chief Administrative Law Judge at the United States International Trade Commission ("ITC") denying Merck's Motion for Summary Determination of Invalidity of U.S. Patent No. 6,086,909. On February 11, 2011, Femina Pharma Incorporated filed a complaint with the ITC for...

2011-07-18 06:30:00

EAST HANOVER, N.J., July 18, 2011 /PRNewswire/ -- Unity Management Group, Inc. (OTC: UYMG) (or "the Company") today announced its wholly owned subsidiary Metropolitan Computing Corporation (or MCC) has received $50,000 in new, annual business awards as result of a maintenance contract request. The maintenance contract request is on MCC's Patented Presster Tablet Press installed at Merck-Schering-Plough. The Company has invested in the development of its Patented Presster Tablet Press as a...